(R)-2-((R)-3-amino-3-(4-((2-methoxyquinolin-4-yl)methoxy)phenyl)-2-oxopyrrolidin-1-yl)-N-hydroxy-4-methylpentanamide

ID: ALA3221862

PubChem CID: 90668119

Max Phase: Preclinical

Molecular Formula: C27H32N4O5

Molecular Weight: 492.58

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1cc(COc2ccc([C@]3(N)CCN([C@H](CC(C)C)C(=O)NO)C3=O)cc2)c2ccccc2n1

Standard InChI:  InChI=1S/C27H32N4O5/c1-17(2)14-23(25(32)30-34)31-13-12-27(28,26(31)33)19-8-10-20(11-9-19)36-16-18-15-24(35-3)29-22-7-5-4-6-21(18)22/h4-11,15,17,23,34H,12-14,16,28H2,1-3H3,(H,30,32)/t23-,27-/m1/s1

Standard InChI Key:  BLDJJEPKWIWCKQ-YIXXDRMTSA-N

Molfile:  

     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   12.2889   -5.7718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6992   -5.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5060   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5935   -6.0494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8409   -6.3817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3627   -4.3022    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3310   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7455   -4.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5705   -4.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9810   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5705   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7455   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8102   -5.2290    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2206   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6956   -5.9418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2852   -6.6545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4602   -6.6545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0456   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4602   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0456   -4.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4602   -3.7992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2852   -3.7992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6956   -4.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2852   -5.2290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1725   -6.6288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4684   -5.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9455   -5.2168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1307   -5.3436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8348   -6.1131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6120   -4.7011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3452   -6.7607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7004   -7.2792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4011   -8.0616    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7046   -7.3798    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2861   -8.1056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5935   -4.4087    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  2  6  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  7 12  2  0
 13 14  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 15 24  1  0
 19 24  1  0
 14 18  1  0
 10 13  1  0
  3  7  1  0
 25 26  1  0
 26 27  1  1
 27 28  1  0
 28 29  1  0
 28 30  1  0
  1 26  1  0
 25 31  2  0
 25 32  1  0
 32 33  1  0
 16 34  1  0
 34 35  1  0
  3 36  1  1
M  END

Alternative Forms

1. Parent:

   

   ALA3221862

   (2R)-2-[(3R)-3-amino-3-[4-[(2-methoxyquinolin-4-yl)methoxy]phenyl]-2-oxopyrrolidin-1-yl]-N-hydroxy-4-methylpentanamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 492.58

Molecular Weight (Monoisotopic): 492.2373

AlogP: 3.13

#Rotatable Bonds: 9

Polar Surface Area: 127.01

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.74

CX Basic pKa: 7.46

CX LogP: 2.86

CX LogD: 2.69

Aromatic Rings: 3

Heavy Atoms: 36

QED Weighted: 0.31

Np Likeness Score: -0.43

References

1. Argade A, Bahekar R, Desai J, Thombare P, Shah K, Gite S, Sunder R, Ranvir R, Bandyopadhyay D, Chakrabarti G, Joharapurkar A, Mahapatra J, Chatterjee A, Patel H, Shaikh M, Sairam KVVM, Jain M, Patel P.  (2011)  Design, synthesis and biological evaluation of -lactam hydroxamate based TACE inhibitors,  2  (10): [10.1039/C0MD00261E]

Source

Source(1):

• Scientific Literature